somatotroph raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-12-01. Anything still debated is marked as such rather than presented as settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | Built on a 29 residue sequence |
| Primary target | GHRH receptor (GHRHR) | Class B G protein coupled receptor |
| Unconjugated half life | Minutes | Limited by protease degradation |
| Key modification | Four residue substitutions | Positions 2, 8, 15 and 27 |
| Common synonym | Modified GRF(1-29) | Usually denotes the form without DAC |
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
==== Binding capacity ==== Proponents of both agarose and magnetic beads can argue whether the vast difference in the binding capacities of the two beads favors one particular type of bead. In a bead-to-bead comparison, agarose beads have significantly greater surface area and therefore a greater binding capacity than magnetic beads due to the large bead size and sponge-like structure. But the variable pore size of the agarose causes a potential upper size limit that may affect the binding of extremely large proteins or protein complexes to internal binding sites, and therefore magnetic beads may be better suited for immunoprecipitating large proteins or protein complexes than agarose beads, although there is a lack of independent comparative evidence that proves either case. Some argue that the significantly greater binding capacity of agarose beads may be a disadvantage because of the larger capacity of non-specific binding. Others may argue for the use of magnetic beads because of the greater quantity of antibody required to saturate the total binding capacity of agarose beads, which would obviously be an economical disadvantage of using agarose. While these arguments are correct outside the context of their practical use, these lines of reasoning ignore two key aspects of the principle of immunoprecipitation that demonstrates that the decision to use agarose or magnetic beads is not simply determined by binding capacity.
It happens rarely, but it is possible for a pancreatitis attack to activate the endocrine portion of the organ back into being capable of producing insulin once again in dogs. It is possible for acute pancreatitis to cause a temporary, or transient diabetes, most likely due to damage to the endocrine portion's beta cells. Insulin resistance that can follow a pancreatitis attack may last for some time thereafter. Pancreatitis can damage the endocrine pancreas to the point where the diabetes is permanent.
Homoserine dehydrogenase catalyzes the reaction of aspartate-semialdehyde (ASA) to homoserine. The overall reaction reduces the C4 carboxylic acid functional group of ASA to a primary alcohol and oxidizes the C1 aldehyde to a carboxylic acid. Residues Glu 208 and Lys 117 are thought to be involved in the active catalytic site of the enzyme. Asp 214 and Lys 223 have been shown to be important for hydride transfer in the catalyzed reaction. Once the C4 carboxylic acid is reduced to an aldehyde and the C1 aldehyde is oxidized to a carboxylic acid, experiments suggest that Asp 219, Glu 208 and a water molecule bind ASA in the active site while Lys 223 donates a proton to the aspartate-semialdehyde C4 oxygen. Homoserine dehydrogenase has an NAD(P)H cofactor, which then donates a hydrogen to the same carbon, effectively reducing the aldehyde to an alcohol. (Refer to figures 1 and 2). However, the precise mechanism of complete homoserine dehydrogenase catalysis remains unknown. The homoserine dehydrogenase-catalyzed reaction has been postulated to proceed through a bi-bi kinetic mechanism, where the NAD(P)H cofactor binds the enzyme first and is the last to dissociate from the enzyme once the reaction is complete. Additionally, while both NADH and NADPH are adequate cofactors for the reaction, NADH is preferred. The Km of the reaction is four-times smaller with NADH and the Kcat/Km is three-times greater, indicating a more efficient reaction. Homoserine dehydrogenase also exhibits multi-order kinetics at subsaturating levels of substrate.
Sources: en.wikipedia.org
histone modification The post-translational modification of histone proteins by the chemical attachment of various molecules or functional groups to specific amino acid residues. Because histones form the core of nucleosomes, the modification of exposed parts of their polypeptide chains is used to regulate gene expression by marking them with molecular labels that signal the recruitment of other proteins to induce conformational changes that variously widen or condense the spacing of nucleosomes along strands of DNA, thereby changing the accessibility of nearby DNA sequences to transcriptional machinery. Histones are modified by many different labels, most commonly methylation, acetylation, ubiquitination, phosphorylation, and citrullination.
In an article published in Foreign Affairs in January 1969, Kissinger criticized General William Westmoreland's attrition strategy because the Vietnamese Communists were willing to accept far higher losses on the battlefield than the United States and could therefore "win" as long as they did not "lose" by merely keeping the war going. In the same article, he argued that losses endured by the Vietnamese Communists in the Tet Offensive were meaningless as the Tet Offensive had turned American public opinion against the war, ruling out the possibility of a military solution, and the best that could be done now was to negotiate the most favorable peace settlement at the Paris peace talks. Kissinger, when he came into office in 1969 favored a negotiating strategy under which the United States and North Vietnam would sign an armistice and agreed to pull their troops out of South Vietnam while the South Vietnamese government and the Viet Cong were to agree to a coalition government. Kissinger had doubts about Nixon's theory of "linkage", believing that this would give the Soviet Union leverage over the United States and, unlike Nixon, was less concerned about the ultimate fate of South Vietnam. One of Kissinger's first acts as National Security Advisor in early 1969 was to seek opinions of the Vietnam experts within the CIA, the military and the State Department.
=== Wound Healing === Recent attention has been drawn to the remarkable wound-healing capabilities and excellent biocompatibility of keratin derived from human hair. While recombinant keratin proteins produced via recombinant DNA technology offer higher purity compared to extracted keratin, their wound-healing properties have remained unclear. Two recombinant trichocyte keratins—human type I hair keratin 37 and human type II hair keratin 81—were expressed using a bacterial expression system and subsequently forming recombinant keratin nanoparticles (RKNPs) through ultrasonic dispersion. It has been revealed that RKNPs significantly boosted cell proliferation and migration in laboratory settings. Moreover, when applied to dermal wounds in vivo, RKNPs facilitated improved wound healing, leading to enhanced epithelialization, vascularization, collagen deposition, and remodeling. Importantly, tests for in vivo biocompatibility showed no signs of systemic toxicity. RKNPs have potential as a promising approach for advancing wound healing and suggests new avenues for developing keratin-based biomaterials.
Sources: en.wikipedia.org
=== Disannexation === In the northern Leribe District, rebel chief Joel Molapo and loyalist chief Jonathan Molapo continued to clash sporadically over the Leribe chieftaincy. Joel continuously attacked local loyalists in an effort to seize power, complicating the settlement of the Gun War. The fighting resulted in a wave of refugees fleeing towards the Orange Free State. A month later, a number of Basuto chiefs including Masopha, failed to appear at a pitso called by Orpen's successor Matt Blyth, thus rejecting Scanlen's new proposal for semi-autonomous rule. Aided by Masopha, Joel Molapo continued to massacre and destroy the properties of his opponents. During one of his raids, his warriors burnt the stone house of his deceased father, which shifted popular opinion against him. In May, Letsie I officially granted Jonathan the Leribe chieftaincy, but despite Letsie's declaration, violence in Leribe did not subside until the end of the year. Facing continued diplomatic protests from the Free State and unable to enforce the law in Basutoland, the Cape Parliament passed the Disannexation Act in September 1883. A pitso held at Maseru on 29 November resulted in most chiefs voting in favor of remaining British subjects. Masopha did not attend the Maseru pitso, holding one of his own; where he demanded complete independence. The British Secretary of State issued an Order-in-Council granting the queen's support to the Disannexation Act, which came into force on 18 March 1884.
small nucleolar RNA (snoRNA) A class of small non-coding RNA molecules whose primary function is to direct the post-transcriptional modification of other RNAs, mainly transfer RNAs (tRNA), small nuclear RNAs (snRNA), and especially ribosomal RNAs (rRNA) as a part of ribosome synthesis in the nucleolus. SnoRNAs contain antisense sequences that complement sequences within these target RNAs and guide ribonucleoprotein complexes to them, which can then catalyze specific nucleoside modifications, typically methylation or pseudouridylation.
=== Mitigate carbon nanotube toxicity via physicochemical modulation === Length, diameter, and aggregation state: As-synthesized CNTs typically form large bundles or agglomerates, which are associated with increased cytotoxicity. Disaggregation into individualized CNTs and cutting length can mitigate toxicity. These modifications are commonly achieved through tip ultrasonication in the presence of surfactants or polymers, followed by ultracentrifugation to remove residual bundles and impurities. Such processing enhances dispersion, reduces rigidity, and improves biocompatibility. Single-type enrichment and classification: Heterogeneity in CNT materials contributes to inconsistent biological responses. Advanced sorting techniques, such as aqueous two-phase extraction, size-exclusion chromatography, and density gradient ultracentrifugation, can sort CNTs by specific parameters such as diameter, length, number of walls, and chirality. Purity enhancement: Post-synthesis purification techniques—such as mild oxidation, sonication in hydrogen peroxide or acetone, acid washing, and incandescent annealing—are employed to remove residual metal catalysts and carbonaceous byproducts. Surface modification: Non-covalent modification: Wrapping CNTs with biocompatible polymers such as single-stranded DNA (ssDNA), phospholipid–polyethylene glycol, or Pluronic F108 enhances solubility, colloidal stability, and biological compatibility without altering the intrinsic structure of the nanotubes.
Sources: en.wikipedia.org
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.
DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.
No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.